Abstract:Ethnopharmacological relevance Transcatheter arterial chemoembolization (TACE) is recommended as the first-line therapy for unresected primary liver cancer (PLC), but only partial patients could benefit from TACE due to the serious adverse reactions. Clearing heat and resolving toxin (CHRT), one of most critical traditional Chinese medicine (TCM) therapeutic principles, has been widely used in the treatment of PLC patients especially after TACE. However, there is no enough clinical evidence to confirm the efficacy and safety of the combined therapy. Aim of the study To comprehensively evaluate the efficacy and safety of the combined CHRT-CHF with TACE in the treatment of PLC. Materials and methods 7 databases were searched from their inception until February 1, 2023. The primary outcomes included survival rate (1-, 2-year), objective response rate (ORR) and disease control rate (DCR), liver function indicators (AST, ALT), adverse reactions including fever, upper digestive tract side and myelosuppression, AFP were selected as the secondary outcomes. RevMan5.4 software was used to evaluate the quality of included studies; meta-analysis, subgroup analysis, meta-regression analysis, publication bias and trial sequential analyses (TSA) was conducted by Stata software 12.0. Results There were 40 RCTs involving 3649 patients. Patients treated with TACE plus CHRT-CHF showed significantly better 1-, 2-year survival (respectively: OR, 2.23 [1.67–2.97]; OR, 2.13 [1.56–2.92]), ORR (OR, 2.14 [1.82–2.52]), DCR (OR, 2.13 [1.73–2.62]) compared with TACE alone. There was a decreased incidence of aspartate transaminase (AST), alanine transaminase (ALT), alpha-fetoprotein (AFP) and postembolization syndrome (PES) in patients receiving the combined TACE with CHRT-CHF compared with TACE alone. Subgroup analysis found that lower proportion (20–30%) of CHRT-CHF significantly enhanced survival rate and DCR, higher proportion (≥40%) of CHRT-CHF reduced PES after TACE treatment. Conclusion The efficacy and safety of the combined CHRT-CHF with TACE were validated in this meta-analysis, the optimal proportion of CHRT-CHF in enhancing the efficacy may be 20–30%; Additionally, higher proportion (≥40%) of CHRT-CHF appears to reduce PES after TACE treatment. The potential role of combined relative proportion of CHRT-CHF with TACE should be emphasized in clinic.

[Clinical Evaluation of Integration of Transcatheter Arterial Chemoembolization and Traditional Chinese Medicine in Treating Metastatic Liver Cancer].

Comparative Study on Clinical Efficacy of Comprehensive Treatment Plan of TCM and TACE in Treatment of Barcelona Stage C Liver Cancer

Traditional Chinese Medicine Plus Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma

Effect of Yiqi Jiedu traditional Chinese medicine plus transcatheter arterial chemoembolization on primary hepatocellular carcinoma and its influence on T lymphocyte subsets,GP - 73 and GPC - 3 levels

Efficacy combined transcatheter arterial chemoembolization(TACE)and radiotherapy for advanced primary liver cancer

[Evaluation of the Efficacy and Prognostic Factors for Colorectal Liver Metastases Treated with Transcatheter Arterial Chemoembolization].

TACE Combined with Thermotherapy for Primary Hepatic Carcinoma; A Meta-Analvsis

Meta-analysis: traditional Chinese medicine for improving immune response in patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.

The therapeutic principle of combined clearing heat and resolving toxin plus TACE on primary liver cancer: A systematic review and meta-analysis

Effect of TACE Combined with Stereotactic Body X-knife on the Patients with Hepatocellular Carcinoma

Clinieal studies on the therapeutic effeets of combined therapy with TACE and Qi-boosting toxin-resolving granule on hepatic carcinoma

The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.

Clinical Investigation of Chemoembolization of Hepatic Artery Combined with Portal Venous in Treating the Moderate and Advanced Hepatic Carcinomas

Evaluation of clinical curative effect of transcatheter arterial chemoembolization combined with capecitabine in the treatment of elderly patients with liver metastases after colorectal cancer surgery

Therapeutic Effect of TACE Combined with Compound Sophora Flavescens Injection in Mid and Advanced Stage Primary Liver Cancer

Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis

Clinical Efficacy of Transcatheter Arterial Chemoembolization Combined With Percutaneous Microwave Coagulation Therapy for Advanced Hepatocellular Carcinoma

Herbal Medication 960 Mixture Combined with Transcatheter Arterial Chemoembolization for Advanced Liver Cancer

Percutaneous microwave coagulation therapy under contras-enhanced grey-scale ultrasonography guidance combined with TACE for the treatment of hepatic metastatic carcinomas

The effect of transcatheter arterial chemoembolization combined with ultrasound-guided radiofrequency ablation on the efficacy and immune function in patients with primary liver cancer

Effect of chemotherapeutics and embolization on tumor inhibition and liver injury in TACE treatment of hepatic carcinoma